We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Store » Shanghai Taiheng Industry Co., Ltd.
The current synthesis process for the crude active pharmaceutical ingredient (API) lacks documented evidence that the critical process parameters are adequately identified, bracketed, and controlled to assure a consistent and reproducible process route that results in pre-defined API quality attributes.